Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus dorsal root ganglion pulsed radiofrequency for herpes zoster neuralgia
ChiCTR2400093061Phase 4Recruiting
- Sponsor
- Department of Pain Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postherpetic neuralgia (PHN) comparing Esketamine group with Placebo group (2 arms). Primary endpoint: Numerical Rating Scale pain score at 48 hours. Started Nov 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on ChiCTR2400093061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093061.